Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05113667
Other study ID # MUHSI-2019/29-78
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2019
Est. completion date August 31, 2021

Study information

Verified date October 2023
Source Marmara University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the impact of clinical pharmacist-led appropriate acid suppression therapy stewardship program in hospitalized older patients.


Description:

This prospective, nonrandomized controlled study was conducted in older patients who ordered proton pump inhibitor (PPI) at admission in an internal medicine service of tertiary training and research hospital. In the intervention group, clinical pharmacist-led services (including medication reconciliation and medication review) were conducted during hospitalization and at discharge by using the guidelines and potentially inappropriate medications (PIM) criteria [American Geriatric Society-AGS Beers Criteria©, 2019]. Medication Appropriateness Index (MAI), inappropriate PPI cost, and hospitalization for gastrointestinal bleeding within 1 year after discharge were calculated in both groups


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date August 31, 2021
Est. primary completion date February 28, 2020
Accepts healthy volunteers No
Gender All
Age group 65 Years to 95 Years
Eligibility Inclusion Criteria: - 65 years old or greater - Admitted to the hospital with any reason - Ordered at least one PPI dose within 48 hours of admission Exclusion Criteria: - Transferred to another ward (including an intensive care unit) - Having active gastrointestinal bleeding - Having active malignity

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program
Clinical pharmacist provided medication reconciliation and medication review during the hospital stay.

Locations

Country Name City State
Turkey Marmara University Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Marmara University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Appropriateness of Proton Pump Inhibitors Usage The rate of appropriateness use of proton pump inhibitors based on the guidelines at hospital stay during hospital stay, an average of 14 days
Primary Potentially Inappropriate Proton Pump Inhibitors Usage The rate of potentially inappropriate use of proton pump inhibitors based on American Geriatric Society Beers Criteria© 2019 at discharge, an average of 14 days after admission to hospital
Secondary Clinical outcome The number of patients who hospitalized for bleeding within 1 year after discharge 1 year
Secondary Cost saving during hospital stay Medication cost for inappropriate PPI during hospital study during hospital stay, an average of 14 days
Secondary Medication Appropriateness Index for Proton Pump Inhibitors at hospital stay Medication Appropriateness Index (MAI); included 10 items. Each item was weighted from 1-3. The highest score per medication was 18.
Higher scores of this index represent more inappropriateness of each medication.
during hospital stay, an average of 14 days
Secondary Cost saving after discharge Medication cost for potentially inappropriate PPI after discharge a month
Secondary Medication Appropriateness Index for Proton Pump Inhibitors at discharge Medication Appropriateness Index (MAI); included 10 items. Each item was weighted from 1-3. The highest score per medication was 18.
Higher scores of this index represent more inappropriateness of each medication.
at discharge, an average of 14 days after admission to hospital
See also
  Status Clinical Trial Phase
Completed NCT04819282 - Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics
Completed NCT04298151 - Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients Phase 2
Completed NCT03139045 - Impact of VeinViewer® Vision to Guide Peripheral Venipuncture in Geriatrics Phase 3
Completed NCT03643432 - Adherence for Exercise Rehabilitation in Older People Trial N/A
Recruiting NCT06102876 - Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study
Recruiting NCT05228782 - COVID-19 and Social Isolation and Loneliness Trial N/A
Recruiting NCT05998343 - Intergenerational Program for Social Isolation and Loneliness in Older Adults Discharged From the Emergency Department N/A
Completed NCT03959475 - A Descriptive Multicenter Investigation of Geriatrics Hotlines : A French Study
Completed NCT05414721 - The Effects of Low Flow and Normal Flow Desflurane Anesthesia N/A
Enrolling by invitation NCT05793138 - Dialysis Geriatric Care Model N/A
Completed NCT05869383 - Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia Phase 2/Phase 3
Completed NCT06307769 - Ten-meter Walking Test With Obstacle in Geriatric Individuals.
Completed NCT02191982 - The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older N/A
Completed NCT04869345 - Positive Affect as a Source of Resilience for Adults in Chronic Pain N/A
Recruiting NCT04965480 - Detecting Delayed Discharge in Acute Geriatric Unit Using Natural Language Processing
Completed NCT04803617 - Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease
Completed NCT03202589 - Assessment for GEriatric Trauma Patients
Active, not recruiting NCT03373682 - Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis N/A
Recruiting NCT05710809 - The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer N/A
Completed NCT05993624 - The Effect of Exergame Games on Geriatric Individuals With Kinesiophobia N/A